Market revenue in 2024 | USD 60.0 million |
Market revenue in 2030 | USD 63.6 million |
Growth rate | 1% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 54.5% in 2024. Horizon Databook has segmented the Sweden hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
In May 2024, the European Centre for Disease Prevention and Control (ECDC) published a report highlighting that Sweden is grappling with elevated rates of healthcare-associated infections (HAIs) in its hospitals.
The report estimates that over 75,000 patients in Swedish acute care hospitals suffer from HAIs annually, leading to increased morbidity, extended hospital stays, and higher healthcare costs. ECDC This concerning trend has prompted Swedish healthcare authorities to intensify efforts in infection prevention and control.
Consequently, there is a growing demand for advanced diagnostic tools capable of early detection and management of HAIs. The increased focus on mitigating infection rates is driving the expansion of the HAI diagnostics market in Sweden, as healthcare facilities seek to implement more effective screening and monitoring solutions to enhance patient safety and care quality.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Sweden hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account